Next Article in Journal
Refining Endoscopic and Combined Surgical Strategies for Giant Pituitary Adenomas: A Tertiary-Center Evaluation of 49 Cases over the Past Year
Next Article in Special Issue
Targeting Hsp70 Immunosuppressive Signaling Axis with Lipid Nanovesicles: A Novel Approach to Treat Pancreatic Cancer
Previous Article in Journal
Patients with Metastatic or Locally Advanced Bladder Cancer Not Undergoing Systemic Oncological Treatment—Characteristics and Long-Term Outcome in a Single-Center Danish Cohort
Previous Article in Special Issue
The Evolution of Anticancer 3D In Vitro Models: The Potential Role of Machine Learning and AI in the Next Generation of Animal-Free Experiments
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Momoli et al. The Evolution of Anticancer 3D In Vitro Models: The Potential Role of Machine Learning and AI in the Next Generation of Animal-Free Experiments. Cancers 2025, 17, 700

Institute for the Organic Synthesis and Photoreactivity—Italian National Research Council, 40129 Bologna, Italy
*
Authors to whom correspondence should be addressed.
These authors contributed equally to this work.
Cancers 2025, 17(7), 1106; https://doi.org/10.3390/cancers17071106
Submission received: 18 March 2025 / Accepted: 19 March 2025 / Published: 26 March 2025
(This article belongs to the Special Issue Novel Therapeutic Approaches for Cancer Treatment)

Addition of Authorship

Beatrice Costa was not included as a first co-author in the original publication [1]. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Momoli, C.; Costa, B.; Lenti, L.; Tubertini, M.; Parenti, M.D.; Martella, E.; Varchi, G.; Ferroni, C. The Evolution of Anticancer 3D In Vitro Models: The Potential Role of Machine Learning and AI in the Next Generation of Animal-Free Experiments. Cancers 2025, 17, 700. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Momoli, C.; Costa, B.; Lenti, L.; Tubertini, M.; Parenti, M.D.; Martella, E.; Varchi, G.; Ferroni, C. Correction: Momoli et al. The Evolution of Anticancer 3D In Vitro Models: The Potential Role of Machine Learning and AI in the Next Generation of Animal-Free Experiments. Cancers 2025, 17, 700. Cancers 2025, 17, 1106. https://doi.org/10.3390/cancers17071106

AMA Style

Momoli C, Costa B, Lenti L, Tubertini M, Parenti MD, Martella E, Varchi G, Ferroni C. Correction: Momoli et al. The Evolution of Anticancer 3D In Vitro Models: The Potential Role of Machine Learning and AI in the Next Generation of Animal-Free Experiments. Cancers 2025, 17, 700. Cancers. 2025; 17(7):1106. https://doi.org/10.3390/cancers17071106

Chicago/Turabian Style

Momoli, Carolina, Beatrice Costa, Lorenzo Lenti, Matilde Tubertini, Marco Daniele Parenti, Elisa Martella, Greta Varchi, and Claudia Ferroni. 2025. "Correction: Momoli et al. The Evolution of Anticancer 3D In Vitro Models: The Potential Role of Machine Learning and AI in the Next Generation of Animal-Free Experiments. Cancers 2025, 17, 700" Cancers 17, no. 7: 1106. https://doi.org/10.3390/cancers17071106

APA Style

Momoli, C., Costa, B., Lenti, L., Tubertini, M., Parenti, M. D., Martella, E., Varchi, G., & Ferroni, C. (2025). Correction: Momoli et al. The Evolution of Anticancer 3D In Vitro Models: The Potential Role of Machine Learning and AI in the Next Generation of Animal-Free Experiments. Cancers 2025, 17, 700. Cancers, 17(7), 1106. https://doi.org/10.3390/cancers17071106

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop